Search

Author/Creator Navada, S.C.

1. 88 BONE MARROW BLAST (BMBL) RESPONSE CORRELATES WITH OVERALL SURVIVAL IN RIGOSERTIB-TREATED PATIENTS WITH HIGHER-RISK MDS AFTER FAILURE OF HYPOMETHYLATING AGENTS (HMAS): A NEW RESPONSE CRITERION?. (April 2015)

Authors:
Silverman, L.R.; Fenaux, P.; Al-Kali, A.; Baer, M.R.; Sekeres, M.; Roboz, G.; Gaidano, G.; Scott, B.; Greenberg, P.; Platzbecker, U.; Steensma, D.P.; Kambhampati, S.; Kreuzer, K.A.; Godley, L.; Collins, R.; Atallah, E.; Navada, S.C.; Azarnia, N.; Garcia-Manero, G.
Journal:
Leukemia research
Issue:
Volume 39(2015:Apr.) Supplement 1
Page Start:
S44
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 89 A PHASE I STUDY OF THE COMBINATION OF AZACITIDINE AND ORAL RIGOSERTIB IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS) OR ACUTE MYELOID LEUKEMIA (AML). Issue 1 (April 2015)

Authors:
Navada, S.C.; Garcia-Manero, G.; Hearn, K.; Odchimar-Reissig, R.; Demakos, E.; Alvarado, Y.; Daver, N.; DiNardo, C.; Konopleva, M.; Borthakur, G.; Azarnia, N.; Silverman, L.R.
Journal:
Leukemia research
Issue:
Volume 39:Issue 1(2015:Jan.)
Page Start:
S45
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search